Regeneron(REGN) - 2021 Q4 - Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2021 Results Conference Call February 4, 2022 8:30 AM ET Company Participants Mark Hudson - Director, IR Dr. Len Schleifer - Co-Founder, President, CEO & Executive Director Dr. George Yancopoulos - Co-Founder, President & Chief Scientific Officer Marion McCourt - EVP and Head of Commercial Bob Landry - EVP & CFO Conference Call Participants Evan Seigerman - BMO Carter Gould - Barclays Tyler Van Buren - Cowen Salveen Richter - Goldman Sachs Ronny Gal - Allianc ...